GDM appears to reshape the placental immune environment through distinct cytokine changes and macrophage polarization. Published in the International Journal of Molecular Sciences, this study examined how hyperglycemia affects immune signaling within the placenta.

The analysis included 40 placentas divided into two groups: 20 from women with GDM and 20 from normoglycemic pregnancies. Villous and extravillous regions were evaluated through flow cytometry and macrophage immunophenotyping. Women with GDM exhibited significantly higher IL-6, IL-8, IL-10, and IL-12p70 levels, indicating amplified inflammatory and regulatory signaling. IL-1β and TNF-α were reduced in the extravillous compartment, suggesting selective downregulation of proinflammatory pathways.

A notable increase in CD14+ cells and M2 macrophages was observed, particularly in the villous portion. This shift toward an M2-predominant profile may represent an adaptive response to metabolic stress, although it may also influence placental function and tissue remodeling.

These findings show that GDM modifies the placental immunological microenvironment, potentially affecting nutrient transfer and fetal development. The study reinforces the importance of evaluating inflammation in pregnancies affected by GDM to better understand risks to maternal and neonatal health.